Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimizing long-term cardiac management after major vascular surgery: Role of beta-blocker therapy, clinical characteristics, and dobutamine stress echocardiography to optimize long-term cardiac management after major vascular surgery.
Kertai MD, Boersma E, Bax JJ, Thomson IR, Cramer MJ, van de Ven LL, Scheffer MG, Trocino G, Vigna C, Baars HF, van Urk H, Roelandt JR, Poldermans D; Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography (DECREASE) Study Group. Kertai MD, et al. Among authors: van de ven ll. Arch Intern Med. 2003 Oct 13;163(18):2230-5. doi: 10.1001/archinte.163.18.2230. Arch Intern Med. 2003. PMID: 14557221
Beta-blockers improve in-hospital and long-term survival in patients with severe left ventricular dysfunction undergoing major vascular surgery.
Feringa HH, Bax JJ, Schouten O, Kertai MD, van de Ven LL, Hoeks S, van Sambeek MR, Klein J, Poldermans D. Feringa HH, et al. Among authors: van de ven ll. Eur J Vasc Endovasc Surg. 2006 Apr;31(4):351-8. doi: 10.1016/j.ejvs.2005.10.018. Epub 2005 Dec 15. Eur J Vasc Endovasc Surg. 2006. PMID: 16359879 Free article.
Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control?
Poldermans D, Bax JJ, Schouten O, Neskovic AN, Paelinck B, Rocci G, van Dortmont L, Durazzo AE, van de Ven LL, van Sambeek MR, Kertai MD, Boersma E; Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo Study Group. Poldermans D, et al. Among authors: van de ven ll. J Am Coll Cardiol. 2006 Sep 5;48(5):964-9. doi: 10.1016/j.jacc.2006.03.059. Epub 2006 Aug 17. J Am Coll Cardiol. 2006. PMID: 16949487 Free article. Clinical Trial.
The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group.
Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blankensteijn JD, Baars HF, Yo TI, Trocino G, Vigna C, Roelandt JR, van Urk H. Poldermans D, et al. Among authors: van urk h, van de ven ll. N Engl J Med. 1999 Dec 9;341(24):1789-94. doi: 10.1056/NEJM199912093412402. N Engl J Med. 1999. PMID: 10588963 Free article. Clinical Trial.
Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy.
Boersma E, Poldermans D, Bax JJ, Steyerberg EW, Thomson IR, Banga JD, van De Ven LL, van Urk H, Roelandt JR; DECREASE Study Group (Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiogrpahy). Boersma E, et al. Among authors: van de ven ll. JAMA. 2001 Apr 11;285(14):1865-73. doi: 10.1001/jama.285.14.1865. JAMA. 2001. PMID: 11308400
Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery.
Poldermans D, Boersma E, Bax JJ, Thomson IR, Paelinck B, van de Ven LL, Scheffer MG, Trocino G, Vigna C, Baars HF, van Urk H, Roelandt JR; Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. Poldermans D, et al. Among authors: van de ven ll. Eur Heart J. 2001 Aug;22(15):1353-8. doi: 10.1053/euhj.2000.2555. Eur Heart J. 2001. PMID: 11465968 Clinical Trial.
Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study.
Schouten O, Poldermans D, Visser L, Kertai MD, Klein J, van Urk H, Simoons ML, van de Ven LL, Vermeulen M, Bax JJ, Lameris TW, Boersma E. Schouten O, et al. Among authors: van de ven ll. Am Heart J. 2004 Dec;148(6):1047-52. doi: 10.1016/j.ahj.2004.05.046. Am Heart J. 2004. PMID: 15632892 No abstract available.
26 results